Karyopharm promotes sohanya cheng to chief commercial officer

Newton, mass., jan. 10, 2022 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq:kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that sohanya cheng has been promoted to chief commercial officer.
KPTI Ratings Summary
KPTI Quant Ranking